MA32885B1 - Nouveaux derives de pyrazolone et leur utilisation en tant qu'inhibiteurs de pd4 - Google Patents

Nouveaux derives de pyrazolone et leur utilisation en tant qu'inhibiteurs de pd4

Info

Publication number
MA32885B1
MA32885B1 MA33922A MA33922A MA32885B1 MA 32885 B1 MA32885 B1 MA 32885B1 MA 33922 A MA33922 A MA 33922A MA 33922 A MA33922 A MA 33922A MA 32885 B1 MA32885 B1 MA 32885B1
Authority
MA
Morocco
Prior art keywords
substituted
inhibitors
pyrazolone
naphtyridinyle
alkyl
Prior art date
Application number
MA33922A
Other languages
Arabic (ar)
English (en)
Inventor
Imre Schlemminger
Beate Schmidt
Dieter Flockerzi
Hermann Tenor
Christof Zitt
Armin Hatzelmann
Degenhard Marx
Clemens Braun
Raimund Külzer
Anke Heuser
Hans-Peter Kley
Geert Jan Sterk
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40427227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32885(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of MA32885B1 publication Critical patent/MA32885B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRÉSENTE INVENTION PORTE SUR LES COMPOSÉS REPRÉSENTÉS PAR LA FORMULE (1) DANS LAQUELLE R1 EST UN DÉRIVÉ PHÉNYLIQUE REPRÉSENTÉ PAR LES FORMULES (A), (B) OU (C); R10 EST ALKYLE C1-C3 ET R11 EST ALKYLE C1-C3, OU R10 ET R11 CONJOINTEMENT AVEC L'ATOME DE CARBONE AUQUEL ILS SONT LIÉS FORMENT UN NOYAU HYDROCARBONÉ DE 3, 4, 5 OU 6 CHAÎNONS À LIAISON SPIRO, A EST C(O) OU S(O)2 ET R12 EST PHÉNYLE, NAPHTALÉNYLE, PYRIDINYLE, QUINOLINYLE, ISOQUINOLINYLE, QUINOXALINYLE, 1,6-NAPHTYRIDINYLE, 1,8-NAPHTYRIDINYLE, INDOLYLE, PHÉNYLE SUBSTITUÉ PAR R13, R14, R15 ET R16, PYRIDINYLE SUBSTITUÉ PAR R17 ET R18, NAPHTALÉNYLE SUBSTITUÉ PAR R19 ET R20, QUINOLINYLE SUBSTITUÉ PAR R21 OU INDOLYLE SUBSTITUÉ PAR R22. CES PRODUITS SONT DE NOUVEAUX INHIBITEURS EFFICACES DE LA PHOSPHODIESTÉRASE DE TYPE 4.
MA33922A 2008-11-14 2011-06-08 Nouveaux derives de pyrazolone et leur utilisation en tant qu'inhibiteurs de pd4 MA32885B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08169143 2008-11-14
US19333308P 2008-11-19 2008-11-19
PCT/EP2009/065031 WO2010055083A1 (fr) 2008-11-14 2009-11-12 Nouveaux dérivés de pyrazolone et leur utilisation comme inhibiteurs de la pd4

Publications (1)

Publication Number Publication Date
MA32885B1 true MA32885B1 (fr) 2011-12-01

Family

ID=40427227

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33922A MA32885B1 (fr) 2008-11-14 2011-06-08 Nouveaux derives de pyrazolone et leur utilisation en tant qu'inhibiteurs de pd4

Country Status (25)

Country Link
US (2) US8609848B2 (fr)
EP (1) EP2356103B1 (fr)
JP (1) JP5599405B2 (fr)
KR (1) KR20110082616A (fr)
CN (1) CN102369194B (fr)
AR (1) AR074318A1 (fr)
AU (1) AU2009315615A1 (fr)
BR (1) BRPI0921335A8 (fr)
CA (1) CA2742922C (fr)
CO (1) CO6331469A2 (fr)
EA (1) EA018585B1 (fr)
EC (1) ECSP11011034A (fr)
ES (1) ES2553754T3 (fr)
GE (1) GEP20135918B (fr)
IL (1) IL212700A0 (fr)
MA (1) MA32885B1 (fr)
ME (1) ME01134B (fr)
MX (1) MX2011005030A (fr)
MY (1) MY154019A (fr)
NZ (1) NZ593262A (fr)
PE (1) PE20110539A1 (fr)
TW (1) TWI460172B (fr)
UA (1) UA105910C2 (fr)
WO (1) WO2010055083A1 (fr)
ZA (1) ZA201102028B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074318A1 (es) * 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
WO2014090990A1 (fr) * 2012-12-13 2014-06-19 Ludwig Aigner Antagonistes de la voie des leucotriènes pour le traitement de la démence, de déficits cognitifs dans la maladie de parkinson et/ou de déficits d'apprentissage et de la mémoire dans la maladie de parkinson
WO2017089347A1 (fr) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Procédés et compositions pharmaceutiques pour le traitement de mélanomes résistant aux inhibiteurs de braf

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2903460A (en) 1956-04-07 1959-09-08 Sandoz Ag Pyrazolone derivatives
US4550119A (en) 1983-05-23 1985-10-29 Warner-Lambert Company 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones
BR9806752A (pt) 1997-01-15 2000-03-14 Byk Gulden Lomberg Chem Fab Ftalazinonas.
CZ20032491A3 (cs) 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
EP1385848A2 (fr) 2001-04-25 2004-02-04 ALTANA Pharma AG Phtalazinones
WO2004018449A1 (fr) 2002-08-10 2004-03-04 Altana Pharma Ag Derives de piperidine utilises comme inhibiteurs de la phospodiesterase-4 (pde4)
EP1556369A1 (fr) 2002-08-10 2005-07-27 ALTANA Pharma AG Derives de pyridazinone utilises comme inhibiteurs de pde4
BR0313330A (pt) 2002-08-10 2005-06-14 Altana Pharma Ag Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
WO2005075457A1 (fr) 2004-02-04 2005-08-18 Altana Pharma Ag Derives de phtalazinone utilises en tant qu'inhibiteurs de pde4
DE602005005638T2 (de) 2004-02-04 2009-05-14 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
PL2589599T4 (pl) 2004-03-03 2015-06-30 Takeda Gmbh Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4
CA2565599C (fr) * 2004-05-18 2012-07-31 Schering Corporation 2-quinolyle-oxazoles substitues utiles comme inhibiteurs du pde4
WO2007092435A2 (fr) 2006-02-07 2007-08-16 Wyeth Inhibiteurs 11-beta hsd1
ES2427442T3 (es) * 2007-05-16 2013-10-30 Takeda Gmbh Derivados de pirazolona como inhibidores de PDE4
JPWO2008156102A1 (ja) 2007-06-19 2010-08-26 杏林製薬株式会社 ピラゾロン誘導体及びそれらを有効成分とするｐｄｅ阻害剤
AR074318A1 (es) * 2008-11-14 2011-01-05 Nycomed Gmbh Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.

Also Published As

Publication number Publication date
GEP20135918B (en) 2013-09-10
CN102369194A (zh) 2012-03-07
TWI460172B (zh) 2014-11-11
ZA201102028B (en) 2011-11-30
NZ593262A (en) 2013-03-28
US8609848B2 (en) 2013-12-17
BRPI0921335A2 (pt) 2017-06-06
BRPI0921335A8 (pt) 2017-12-05
ME01134B (fr) 2013-03-20
MY154019A (en) 2015-04-30
US20140073672A1 (en) 2014-03-13
WO2010055083A1 (fr) 2010-05-20
HK1167406A1 (zh) 2012-11-30
US20110218201A1 (en) 2011-09-08
UA105910C2 (uk) 2014-07-10
KR20110082616A (ko) 2011-07-19
EA201100740A1 (ru) 2012-01-30
EP2356103B1 (fr) 2015-08-26
TW201022228A (en) 2010-06-16
CO6331469A2 (es) 2011-10-20
CN102369194B (zh) 2014-08-27
EA018585B1 (ru) 2013-09-30
MX2011005030A (es) 2011-05-30
JP5599405B2 (ja) 2014-10-01
ECSP11011034A (es) 2011-06-30
EP2356103A1 (fr) 2011-08-17
IL212700A0 (en) 2011-07-31
AU2009315615A1 (en) 2011-06-30
JP2012508720A (ja) 2012-04-12
PE20110539A1 (es) 2011-08-04
CA2742922C (fr) 2018-02-27
ES2553754T3 (es) 2015-12-11
US9340522B2 (en) 2016-05-17
CA2742922A1 (fr) 2010-05-20
AR074318A1 (es) 2011-01-05

Similar Documents

Publication Publication Date Title
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
MX353957B (es) Carboxamidas heterociclicas fungicidas.
AR094887A1 (es) Derivado de tetrahidroimidazol[1,5-d][1,4]oxazepina
EA201170099A1 (ru) Замещенные пиримидин-4-оновые производные
IN2012DN00573A (fr)
MEP10009A (en) 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-hpyrrole derivatives as acid secretion inhibitors
SMT201300085B (it) Composti di pirrolo
NO20074071L (no) Hydrazinometyl, hydrozonometyl og 5-leddete heterocykliske forbindelser som virker som MTOR inhibitorer og anvendelse derav som anti-cancer midler
WO2012033858A3 (fr) Petites molécules contenant du bore
EA201170096A1 (ru) Замещенные производные пиримидона
EA201071112A1 (ru) ПРОИЗВОДНЫЕ ПОЛИЗАМЕЩЁННЫХ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ ИХ В ТЕРАПИИ
ATE502920T1 (de) Indole und ihre therapeutische verwendung
ES2530449T3 (es) Inhibidores de Syk de imidazopiridinas
EP2597088A4 (fr) Antagoniste des récepteurs p2x4
DE602004022404D1 (de) 4-anilino-chinazolin-derivate als proliferationshemmende mittel
DOP2010000194A (es) Derivados de oxadiazol activos sobre fosfato de esfingosina-1
MY169179A (en) Novel piperidine compound or salt thereof
MX2009011769A (es) Derivados de piridona como inhibidores de mapk p38a.
WO2009095792A3 (fr) Dérivés d'hétéroarylamide diazépinopyrimidone substitués
ATE532780T1 (de) Chinoline und ihre therapeutische verwendung
MA32885B1 (fr) Nouveaux derives de pyrazolone et leur utilisation en tant qu'inhibiteurs de pd4
EA201170844A1 (ru) Ингибиторы цистеинпротеазы
NO20072454L (no) Pyridinderivater, fremstillingen og den terapeutiske anvendelse derav
MX2016003630A (es) Compuestos heterociclicos de n-acilimino.
AR086915A1 (es) Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene